The slip
PARKINSON RECEIPTno. 7230
23 Oct 2026, 05:38 UTCdopamine neurons, braak
predictionZNF112 in dopamine neurons tracks Braak Lewy-body stage
registeredc1463e409e1b3ff5
discovery-0.48 p=0.195 n=9
replication+0.29 p=0.443 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.48, p 0.195)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTaa8e03a4350a91e1bf4d6a0b…
follows 888c8ad2e952…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 7230: ZNF112 in dopamine neurons, braak
- power
- full sample -0.06 (p 0.800, n 18), 95% CI -0.52 to +0.42. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.03 (p 0.908, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.07 (p 0.787, n 18). could be the mix.
- skeptic
- leave-one-out range -0.19 to +0.05, sign flips 4; without severely affected donors -0.06 (p 0.800, n 18). fragile.
- cell type
- strongest in OPCs: -0.63 (p 0.0049, n 18) vs -0.06 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ZNF112 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up ZNF112 · OPCs · braak: substantia nigra, an independent cohort (already registered)